These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study. Martinez C; Wallenhorst C; Rietbrock S; Freedman B J Am Heart Assoc; 2020 Jan; 9(2):e014376. PubMed ID: 31937194 [TBL] [Abstract][Full Text] [Related]
29. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study. Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369 [TBL] [Abstract][Full Text] [Related]
30. Comorbidities in combined retinal artery and vein occlusions. Schmidt D Eur J Med Res; 2013 Aug; 18(1):27. PubMed ID: 23947749 [TBL] [Abstract][Full Text] [Related]
31. Atrial ectopic activity in cryptogenic ischemic stroke and TIA: a risk factor for recurrence. Pinho J; Braga CG; Rocha S; Santos AF; Gomes A; Cabreiro A; Magalhães S; Ferreira C J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):507-10. PubMed ID: 25533759 [TBL] [Abstract][Full Text] [Related]
32. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Diener HC; Eikelboom J; Connolly SJ; Joyner CD; Hart RG; Lip GY; O'Donnell M; Hohnloser SH; Hankey GJ; Shestakovska O; Yusuf S; Lancet Neurol; 2012 Mar; 11(3):225-31. PubMed ID: 22305462 [TBL] [Abstract][Full Text] [Related]
33. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Schmidt M; Bøtker HE; Pedersen L; Sørensen HT Eur J Epidemiol; 2014 Feb; 29(2):111-8. PubMed ID: 24337942 [TBL] [Abstract][Full Text] [Related]
34. Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. Fangel MV; Nielsen PB; Larsen TB; Christensen B; Overvad TF; Lip GYH; Goldhaber SZ; Jensen MB Int J Cardiol; 2018 Oct; 268():137-142. PubMed ID: 30041778 [TBL] [Abstract][Full Text] [Related]
35. Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study. Yuan Z; Makadia R; Ryan P; Yannicelli D; Nessel C; Sarich T Curr Med Res Opin; 2015; 31(7):1257-66. PubMed ID: 25877807 [TBL] [Abstract][Full Text] [Related]
36. Association of CHA Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240 [TBL] [Abstract][Full Text] [Related]
37. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores. Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920 [TBL] [Abstract][Full Text] [Related]
38. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Barnes ME; Miyasaka Y; Seward JB; Gersh BJ; Rosales AG; Bailey KR; Petty GW; Wiebers DO; Tsang TS Mayo Clin Proc; 2004 Aug; 79(8):1008-14. PubMed ID: 15301328 [TBL] [Abstract][Full Text] [Related]
39. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209 [TBL] [Abstract][Full Text] [Related]
40. The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study. Saliba W; Gronich N; Barnett-Griness O; Rennert G J Thromb Haemost; 2016 Jun; 14(6):1155-62. PubMed ID: 27037960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]